These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 1349391)

  • 1. Successful in-vitro fertilisation and embryo transfer after treatment with recombinant human FSH.
    Germond M; Dessole S; Senn A; Loumaye E; Howles C; Beltrami V
    Lancet; 1992 May; 339(8802):1170. PubMed ID: 1349391
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful in-vitro fertilisation and embryo transfer after treatment with recombinant human FSH.
    Devroey P; van Steirteghem A; Mannaerts B; Bennink HC
    Lancet; 1992 May; 339(8802):1170. PubMed ID: 1349390
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
    Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of outcomes from in vitro fertilization cycles stimulated with either recombinant luteinizing hormone (LH) or human chorionic gonadotropin acting as an LH analogue delivered as human menopausal gonadotropins, in subjects with good or poor ovarian reserve: a retrospective analysis.
    Dahan MH; Agdi M; Shehata F; Son W; Tan SL
    Eur J Obstet Gynecol Reprod Biol; 2014 Jan; 172():70-3. PubMed ID: 24314801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of highly purified versus recombinant follicle stimulating hormone on oocyte quality and embryo development in intracytoplasmic sperm injection cycles.
    Murber A; Fancsovits P; Ledó N; Szakács M; Rigó J; Urbancsek J
    Acta Biol Hung; 2011 Sep; 62(3):255-64. PubMed ID: 21840828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of recombinant human follicle-stimulating hormone for in vitro fertilization-embryo transfer after severe systemic immunoglobulin E-mediated reaction to urofollitropin.
    Phipps WR; Holden D; Sheehan RK
    Fertil Steril; 1996 Jul; 66(1):148-50. PubMed ID: 8752627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovarian stimulation protocols based on follicle-stimulating hormone glycosylation pattern: impact on oocyte quality and clinical outcome.
    Selman H; Pacchiarotti A; El-Danasouri I
    Fertil Steril; 2010 Oct; 94(5):1782-6. PubMed ID: 19939369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment outcome of women with a single ovary undergoing in vitro fertilisation cycles.
    Hendricks MS; Chin H; Loh SF
    Singapore Med J; 2010 Sep; 51(9):698-701. PubMed ID: 20938609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modified natural cycle for in vitro fertilization and embryo transfer in normal ovarian responders.
    Lou HY; Huang XY
    J Int Med Res; 2010; 38(6):2070-6. PubMed ID: 21227012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Results of IVF and ET 1992-95 at the Gynecological-Obstetrical Clinic in Olomouc--comparison of stimulation protocols].
    Oborná I; Talas M; Dostál J; Chrastinová L; Kudela M
    Ceska Gynekol; 1996 Dec; 61(6):349-51. PubMed ID: 8998585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant follicle-stimulating hormone and recombinant luteinizing hormone versus recombinant follicle-stimulating hormone alone during GnRH antagonist ovarian stimulation in patients aged ≥35 years: a randomized controlled trial.
    Vuong TN; Phung HT; Ho MT
    Hum Reprod; 2015 May; 30(5):1188-95. PubMed ID: 25740882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Assisted embryo hatching].
    Olivennes F; Vincent Y; Bergere M; Selva J; Frydman R
    Contracept Fertil Sex; 1993 Dec; 21(12):911-3. PubMed ID: 8130825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Highly purified FSH for stimulation of down regulated cycles in the in vitro fertilization program].
    Sydow P; Lisse K; Schürenkämper P; Scheiber I; Bloechle M
    Geburtshilfe Frauenheilkd; 1996 Mar; 56(3):146-50. PubMed ID: 8674961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pregnancy and birth of monozygous female twins following in vitro fertilization and embryo transfer].
    Mettler L; Riedel HH; Grillo M; Michelmann HW; Baukloh V; Weisner D; Semm K; Bastert G; Hack HJ
    Geburtshilfe Frauenheilkd; 1984 Oct; 44(10):670-6. PubMed ID: 6394419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of purified gonadotrophins for ovarian stimulation in IVF.
    Jones GS
    Clin Obstet Gynaecol; 1985 Dec; 12(4):775-84. PubMed ID: 3938687
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy of recombinant human follicle-stimulating hormone in improving oocyte quality in assisted reproductive techniques.
    Cheon KW; Byun HK; Yang KM; Song IO; Choi KH; Yoo KJ
    J Reprod Med; 2004 Sep; 49(9):733-8. PubMed ID: 15493565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A randomized, controlled trial comparing follicle stimulating hormone (FSH) to human menopausal gonadotropin (hMG) in fertilization in vitro].
    Daya S; Gumby J; Hughes EG; Collins JA; Sagle MA
    Contracept Fertil Sex; 1995 Dec; 23(12):766-71. PubMed ID: 8556078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of highly purified human menopausal gonadotropin vs. recombinant follicle-stimulating hormone in first-cycle in vitro fertilization-intracytoplasmic sperm injection patients.
    Hompes PG; Broekmans FJ; Hoozemans DA; Schats R;
    Fertil Steril; 2008 Jun; 89(6):1685-93. PubMed ID: 17681325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oocyte retrieval for in vitro fertilization.
    Diedrich K; Van der Ven H; Al-Hasani S; Werner A; Krebs D
    Ann Biol Clin (Paris); 1987; 45(3):351-7. PubMed ID: 2959179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Results of application of high daily doses of recombinant follicle stimulating hormone in different age groups of women in IVF program].
    Tsagareishvili GG; Khonelidze NL; Lazarev AP
    Georgian Med News; 2005 Jun; (123):7-12. PubMed ID: 16052045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.